Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 14.34 USD -0.14% Market Closed
Market Cap: 156.9m USD

Intrinsic Value

The intrinsic value of one MED stock under the Base Case scenario is 15.69 USD. Compared to the current market price of 14.34 USD, Medifast Inc is Undervalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MED Intrinsic Value
15.69 USD
Undervaluation 9%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Medifast Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MED
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MED cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Medifast Inc
NYSE:MED
US
Consumer products
Market Cap
156.9m USD
IPO
Dec 30, 1993
US
Consumer products
Market Cap
156.9m USD
IPO
Dec 30, 1993
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MED?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Medifast Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medifast Inc

Current Assets 214.4m
Cash & Short-Term Investments 162.3m
Other Current Assets 52.1m
Non-Current Assets 69.8m
PP&E 48.7m
Other Non-Current Assets 21.1m
Efficiency

Free Cash Flow Analysis
Medifast Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medifast Inc

Revenue
602.5m USD
Cost of Revenue
-157.8m USD
Gross Profit
444.6m USD
Operating Expenses
-425.2m USD
Operating Income
19.5m USD
Other Expenses
-17.4m USD
Net Income
2.1m USD
Fundamental Scores

MED Profitability Score
Profitability Due Diligence

Medifast Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
58/100
Profitability
Score

Medifast Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

MED Solvency Score
Solvency Due Diligence

Medifast Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
77/100
Solvency
Score

Medifast Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MED Price Targets Summary
Medifast Inc

Wall Street analysts forecast MED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 16.07 USD with a low forecast of 15.15 USD and a high forecast of 17.33 USD.

Lowest
Price Target
15.15 USD
6% Upside
Average
Price Target
16.07 USD
12% Upside
Highest
Price Target
17.33 USD
21% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MED Insider Trading
Buy and sell transactions by insiders

MED News

Other Videos
What is the Intrinsic Value of one MED stock?

The intrinsic value of one MED stock under the Base Case scenario is 15.69 USD.

Is MED stock undervalued or overvalued?

Compared to the current market price of 14.34 USD, Medifast Inc is Undervalued by 9%.

Back to Top